Showing 1 - 20 results of 51 for search 'Teresa Troiani', query time: 0.04s
Refine Results
-
1
Current Landscape and Open Questions on Adjuvant Therapies in Melanoma by Vincenzo De Falco, Stefania Napolitano, Luigi Pio Guerrera, Teresa Troiani
Published 2021-07-01
Article -
2
-
3
-
4
-
5
-
6
NMR Profiling of <i>Ononis diffusa</i> Identifies Cytotoxic Compounds against Cetuximab-Resistant Colon Cancer Cell Lines by Vittoria Graziani, Nicoletta Potenza, Brigida D’Abrosca, Teresa Troiani, Stefania Napolitano, Antonio Fiorentino, Monica Scognamiglio
Published 2021-05-01
Article -
7
-
8
A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells by Nicola Landi, Vincenza Ciaramella, Sara Ragucci, Angela Chambery, Fortunato Ciardiello, Paolo V. Pedone, Teresa Troiani, Antimo Di Maro
Published 2023-01-01
Article -
9
-
10
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review by Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, Marina Cipullo, Mario Romeo, Giovanna Palladino, Patrizia Iodice, Alessandro Federico, Teresa Troiani
Published 2024-01-01
Article -
11
-
12
PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples by Andrea Ronchi, Federica Zito Marino, Elvira Moscarella, Gabriella Brancaccio, Giuseppe Argenziano, Teresa Troiani, Stefania Napolitano, Renato Franco, Immacolata Cozzolino
Published 2022-03-01
Article -
13
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of “difficult to treat” non melanoma skin cancer by Federico Gagliardi, Anna Russo, Camila Scharf, Alessandro Pinto, Mario Faenza, Emma D'Ippolito, Giuseppe Argenziano, Teresa Troiani, Alfonso Reginelli, Valerio Nardone
Published 2024-05-01
Article -
14
Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells by Rosita Russo, Nunzia Matrone, Valentina Belli, Davide Ciardiello, Mariangela Valletta, Sabrina Esposito, Paolo Vincenzo Pedone, Fortunato Ciardiello, Teresa Troiani, Angela Chambery
Published 2019-09-01
Article -
15
Spectroscopic Characterization and Cytotoxicity Assessment towards Human Colon Cancer Cell Lines of Acylated Cycloartane Glycosides from <i>Astragalus boeticus</i> L. by Vittoria Graziani, Assunta Esposito, Monica Scognamiglio, Angela Chambery, Rosita Russo, Fortunato Ciardiello, Teresa Troiani, Nicoletta Potenza, Antonio Fiorentino, Brigida D’Abrosca
Published 2019-05-01
Article -
16
Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion by Giuseppe Argenziano, Maria Concetta Fargnoli, Fabrizio Fantini, Massimo Gattoni, Giulio Gualdi, Francesco Pastore, Giovanni Pellacani, Pietro Quaglino, Paola Queirolo, Teresa Troiani
Published 2022-01-01
Article -
17
-
18
Dramatic Therapeutic Response to Dabrafenib Plus Trametinib in BRAF V600E Mutated Papillary Craniopharyngiomas: A Case Report and Literature Review by Morena Fasano, Carminia Maria Della Corte, Marianna Caterino, Mario Pirozzi, Raffaele Rauso, Teresa Troiani, Giulia Martini, Stefania Napolitano, Floriana Morgillo, Fortunato Ciardiello
Published 2022-01-01
Article -
19
Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events by Remo Poto, Teresa Troiani, Gjada Criscuolo, Gjada Criscuolo, Giancarlo Marone, Fortunato Ciardiello, Carlo Gabriele Tocchetti, Gilda Varricchi, Gilda Varricchi, Gilda Varricchi, Gilda Varricchi
Published 2022-03-01
Article -
20
CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCR... by Stefania Napolitano, Giulia Martini, Davide Ciardiello, Davide Ciardiello, Massimo Di Maio, Nicola Normanno, Antonio Avallone, Erika Martinelli, Evaristo Maiello, Teresa Troiani, Fortunato Ciardiello
Published 2022-06-01
Article